Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8086
Gene Symbol: AAAS
AAAS
0.010 GeneticVariation phenotype BEFREE Myoclonus and generalized digestive dysmotility in triple A syndrome with AAAS gene mutation. 15022193 2004
Entrez Id: 16
Gene Symbol: AARS1
AARS1
0.100 Biomarker phenotype HPO
Entrez Id: 10347
Gene Symbol: ABCA7
ABCA7
0.100 Biomarker phenotype HPO
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.100 Biomarker phenotype HPO
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.100 Biomarker phenotype HPO
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.120 Biomarker phenotype HPO
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.120 GeneticVariation phenotype BEFREE We performed a screening of the entire ADCY5 coding sequence in 44 unrelated subjects with genetically undiagnosed childhood-onset hyperkinetic movement disorders, featuring chorea alone or in combination with myoclonus and dystonia. 28511835 2017
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.120 GeneticVariation phenotype BEFREE Facial twitches in ADCY5-associated disease - Myokymia or myoclonus? An electromyography study. 28442302 2017
Entrez Id: 151
Gene Symbol: ADRA2B
ADRA2B
0.100 Biomarker phenotype HPO
Entrez Id: 158
Gene Symbol: ADSL
ADSL
0.100 Biomarker phenotype HPO
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.110 Biomarker phenotype HPO
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.110 GeneticVariation phenotype BEFREE Because the same genotype was described in six cases from a Tunisian family with a typical AOA2 without myoclonus, we speculate this latter feature is associated with a second mutated gene, namely AFG3L2 (p.Gly116Arg variant). 25927548 2015
Entrez Id: 275
Gene Symbol: AMT
AMT
0.100 Biomarker phenotype HPO
Entrez Id: 63982
Gene Symbol: ANO3
ANO3
0.110 GeneticVariation phenotype BEFREE In summary, ANO3 causes a varied phenotype of young-onset or adult-onset craniocervical dystonia with tremor and/or myoclonic jerks. 24442708 2014
Entrez Id: 63982
Gene Symbol: ANO3
ANO3
0.110 Biomarker phenotype HPO
Entrez Id: 8120
Gene Symbol: AP3B2
AP3B2
0.100 Biomarker phenotype HPO
Entrez Id: 9907
Gene Symbol: AP5Z1
AP5Z1
0.100 Biomarker phenotype HPO
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 GeneticVariation phenotype BEFREE The rare presence of frontal lobe characteristics was associated with a younger age of onset, an increased incidence of myoclonus at presentation, a positive family history but not with possession of APOE epsilon4 allele. 17941342 2007
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 Biomarker phenotype BEFREE We have studied the relationship between the apolipoprotein E gene (APOE) and the development of myoclonus, tremors, rigidity and seizures in 168 patients with probable early-onset Alzheimer's disease (AD). 8803820 1996
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 Biomarker phenotype BEFREE Because the decline in mental ability as well as the development of myoclonus and extrapyramidal signs are consistent manifestations of disease progression, our results imply that APOE epsilon4 is associated with a less aggressive form of AD. 9153523 1997
Entrez Id: 351
Gene Symbol: APP
APP
0.120 GeneticVariation phenotype BEFREE Myoclonus and seizures were the most common additional neurological features; individuals with myoclonus (40 [47%] with PSEN1 mutations and 12 [33%] with APP mutations) were significantly more likely to develop seizures (p=0·001 for PSEN1; p=0·036 for APP), which affected around a quarter of the patients in each group (20 [24%] and nine [25%], respectively). 27777022 2016
Entrez Id: 351
Gene Symbol: APP
APP
0.120 GeneticVariation phenotype BEFREE FAD tends to have prominent myoclonus and this is shared by the cases with APP mutations. 8239283 1993
Entrez Id: 351
Gene Symbol: APP
APP
0.120 Biomarker phenotype HPO
Entrez Id: 64801
Gene Symbol: ARV1
ARV1
0.100 Biomarker phenotype HPO
Entrez Id: 170302
Gene Symbol: ARX
ARX
0.100 Biomarker phenotype HPO